Search research articles
Contact Us
Filters
Showing results (211-220 of 228) with videos related to
Page
of 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR
Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Andrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.
Nature Medicine
|
July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci, Anna Burford, Valeria Molinari, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 228) with videos related to
Sort By:
Page
of 23
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR
Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Andrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.
Nature Medicine
|
July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci, Anna Burford, Valeria Molinari, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Page
of 23